title: PICNIC (Pediatric Investigators Collaborative Network on Infections in Canada) study of the role of age and respiratory syncytial virus neutralizing antibody on respiratory syncytial virus illness in patients with underlying heart or lung disease.
abstract: OBJECTIVE
  To determine the effects of age and respiratory syncytial virus (RSV) antibody status on frequency and severity of RSV infections in children with underlying heart or lung disease.
  
  
  METHODS
  Cohort study conducted during two consecutive RSV seasons.
  
  
  METHODS
  Ambulatory patients at eight Canadian pediatric tertiary care centers.
  
  
  METHODS
  Subjects under 3 years old with underlying heart disease who were digoxin-dependent or had not received corrective cardiac surgery or with underlying lung disease were enrolled. Demographic information and an acute sera for RSV neutralizing antibody was obtained on enrollment. Weekly telephone follow-up consisting of a respiratory illness questionnaire was followed with a home visit to obtain a nasopharyngeal aspirate when there was new onset of respiratory symptoms. The specimen was used to detect RSV antigen. RSV illnesses were grouped as upper or lower respiratory tract infection (LRI) based on clinical and radiographic findings. RSV hospitalizations were considered to be those RSV infections that resulted in hospitalization.
  
  
  RESULTS
  Of 427 enrolled subjects, 160 had underlying lung disease only, 253 had underlying heart disease only, and 14 had both. Eleven percent and 12% of lung and heart disease groups, respectively, had an RSV LRI. Three percent and 6% of lung and heart disease groups, respectively, were hospitalized with RSV infection. A significant decrease in frequency of RSV LRI and RSV hospitalization occurred with increasing age, with a major drop in those older than 1 year vs those younger than 1 year. Acute sera were available from 422 subjects. Geometric mean RSV antibody titers demonstrated a U-shaped distribution with increasing age. The trend to lower antibody concentrations in premature infants did not reach statistical significance. The frequency of RSV infection and RSV LRI was lower in patients with antibody at a titer more than 100, although the difference for RSV hospitalization was not statistically significant. These differences remained significant after age adjustment.
  
  
  CONCLUSIONS
  Both age and RSV antibody status impact on RSV illness and LRI. Reduction in illness frequency with increasing age may lead to more informed targeting of those children most likely to benefit from RSV immune globulin prophylaxis.
authors.affiliation: Hospital for Sick Children and University of Toronto, Toronto, Ontario, Canada.
authors.forename: E E
authors.initials: EE
authors.lastname: Wang
authors.forename: B J
authors.initials: BJ
authors.lastname: Law
authors.forename: J L
authors.initials: JL
authors.lastname: Robinson
authors.forename: S
authors.initials: S
authors.lastname: Dobson
authors.forename: S
authors.initials: S
authors.lastname: al Jumaah
authors.forename: D
authors.initials: D
authors.lastname: Stephens
authors.forename: F D
authors.initials: FD
authors.lastname: Boucher
authors.forename: J
authors.initials: J
authors.lastname: McDonald
authors.forename: I
authors.initials: I
authors.lastname: Mitchell
authors.forename: N E
authors.initials: NE
authors.lastname: MacDonald
mesh_terms: D017677:Age Distribution; D000367:Age Factors; D000914:Antibodies, Viral / Q000097:blood*; D002675:Child, Preschool; D002908:Chronic Disease; D015331:Cohort Studies; D005260:Female; D006330:Heart Defects, Congenital / Q000150:complications*; D006760:Hospitalization / Q000706:statistics & numerical data; D006801:Humans; D015994:Incidence; D007223:Infant; D007234:Infant, Premature; D008171:Lung Diseases / Q000150:complications*; D008297:Male; D018357:Respiratory Syncytial Virus Infections / Q000145:classification / Q000150:complications / Q000276:immunology*; D012136:Respiratory Syncytial Viruses / Q000276:immunology* / Q000302:isolation & purification; D012141:Respiratory Tract Infections / Q000145:classification / Q000150:complications / Q000276:immunology
chemical_list: D000914:Antibodies, Viral